TABLE 1

Patient Demographic Data

Patient	Age (y)	Injected dose (MBq)	Tracer mass (μg)	Cancer type	Ki-67 (%)	Mitotic index	Visual score	T/N	SUV	DVR	T/M
Dynamic patients
1	63	133.2	1.23	H & N	97	7.2	++	2.3	4.0	1.3	4.1
2	46	299.7	1.29	Breast	40	4.3	++	0.9	1.3	1.6	2.8
3	50	296	0.95	H & N	4	3.4	+	1.1	2.0	1.0	1.9
4	64	296	NA	H & N	30	2.3	+	1.1	3.5	1.2	2.3
5	47	296	2.31	Breast	7	0.4	++	3.9	3.5	3.3	4.4
6	80	296	NA	Lymph	12	0.0	++	2.4	4.3	2.7	3.3
7	38	292.3	1.15	Breast	40	1.2	+	1.8	3.1	2.2	3.4
8	42	284.9	1.61	Breast	53	5	+	1.6	3.4	2.2	6.8
9	46	296	2.29	Lymph	37	1	++	2.5	3.8	2.5	6.3
10	45	296	2.65	Breast1	<5	0.5	++	1.2	2.0	1.3	2.0
				Breast2	22	0.6	++	1.5	2.4	1.4	2.4
11	68	296	2.76	Lymph	37	0.7	++	1.7	2.8	2.1	3.5
12	76	296	1.86	Lymph	63	Necrotic	+++	5.0	11.1	2.7	11.1
13	67	292.3	1.62	Breast	23	1.2	+	1.2	2.0	1.4	2.8
14	41	296	4.30	Breast	<5	0	+	1.3	1.9	1.2	3.2
15	56	296	2.10	Breast	8	0.3	+	1.2	1.4	1.7	2.0
16	55	296	3.94	Breast	7.3	0.3	+	1.9	1.7	1.3	2.1
17	50	292.3	2.05	Breast	5	0.1	++	2.1	2.3	1.2	2.8
18	60	292.3	NAv	Breast	5.3	0.4	++	2.9	2.3	2.4	2.1
Dosimetry patients
1	53	99	0.99	Lymph	87	11.1	++	2.8	5.1	NA	3.8
2	64	296	0.85	H & N	63	5.0	+	1.3	3.1	NA	2.7
3	52	296	1.93	H & N	87	13.1	++	1.1	1.9	NA	3.2
4	51	296	2.12	Breast	70	4.0	+	1.2	1.9	NA	3.0
5	70	296	NAv	H & N	80	10.3	++	1.4	3.0	NA	4.3
6	42	296	2.90	Lymph	67	3.5	++	4.5	3.3	NA	4.5
7	60	303	1.59	H & N	37	2.2	+	1.2	2.0	NA	4.0
8	70	296	4.30	H & N	73	2.4	++	2.0	2.9	NA	2.9
9	50	292	1.45	H & N	33	3	+	1.1	2.0	NA	4.0
10	52	285	NAv	Lymph	47	1	+++	2.3	8.4	NA	14.0
11	31	292	2.80	H & N	47	1	+	1.3	2.3	NA	3.8
12	69	296	2.18	Breast	20	1.8	+	1.5	1.4	NA	1.7

+ = minimal uptake; ++ = moderate uptake; +++ = marked uptake; H & N = head and neck; lymph = lymphoma; NA = not applicable; NAv = not available.